# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001437749-25-013863
Filing Date
2025-04-30
Accepted
2025-04-30 16:20:04
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tgtars.pdf | ARS | 1348091
| Complete submission text file | 0001437749-25-013863.txt |  | 1858485

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-32639 | Film No.: 25895697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)